Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said ...
Research teams make progress against Parkinson's origins and effects
Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...
Messenger News3h
Learn about effects, treatments for Parkinson’s disease
Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...
Yahoo6d
New Drug May Prevent Cognitive Decline in Parkinson's Disease
"When patients are diagnosed with Parkinson's disease, 25-30 percent already have mild cognitive impairment," says ...
Daily18h
Chronic musculoskeletal pain independently linked to incidence of Parkinson's disease: Study
A new study published in the journal of Movement Disorders showed that Parkinson's disease (PD) was found to be independently ...
Scientists Identify Protein That Could Alleviate Parkinson’s Disease
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study
AbbVie Inc. (NYSE:ABBV) revealed topline results from its pivotal Phase 3 TEMPO-2 trial, which evaluated investigational ...
sciencex8d
World-first clinical trial hopes to stop Parkinson's in its tracks
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...